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The last 20 years have seen advances in the sur-
gical treatment of threatened limbs and an increas-
ing willingness to pursue aggressive revascularization
through bypass grafting or angioplasty. As a result,
many patients who in the past would have under-
gone a primary amputation for severe ischemia or
ischemia leading to nonhealing wounds now may
have their limb salvaged with the use of microsurgi-
cal techniques or angioplasty.1 With these aggressive
techniques, centers have reported limb salvage rates
of more than 80%.2-5
Information regarding the surgical outcomes of
these revascularizations has primarily examined limb
salvage rates and the patency rates of the revascular-
ization over time. Although there are some varia-
tions with the locations of the disease, primary
patency rates in the year after bypass grafting are in
the 80% range and decline slowly after that to the
60% to 70% range at 4 years.6,7 Angioplasty has
achieved a somewhat poorer primary patency rate in
the 50% to 60% range at 1 year.6
Although patency is important for the assess-
ment of the intervention itself, the point of the
intervention is to preserve the limb. A number of
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studies have shown that limb salvage rates over time
are similar to or somewhat better than the patency
rates discussed previously.2-4,8-10
It must be remembered that those patients who
require limb salvage have high rates of other comor-
bid diseases, including coronary artery disease, cere-
brovascular disease, and diabetes, which may also
influence the patient’s quality of life and functional
status.11 For example, Schneider et al12 found that,
at a mean of 27 months after peripheral vascular
surgery, patients who had a functioning graft still
had a quality of life that was significantly worse than
that of the patients without chronic disease in the
medical outcomes study even after adjusting for
comorbidities. In a small study, Duggan et al13
found no statistically significant difference in quality
of life (measured by the SF-36 at an average of 18
months after surgery) between patients who had
undergone a successful limb salvage procedure and
those who had not. The longer term implications of
limb revascularization on quality of life and func-
tional status are unclear. To address this question,
we examined the functional status outcomes and
quality of life of patients for up to 7 years after
undergoing revascularization at the University of
Minnesota Hospital. 
METHODS
With the University of Minnesota Hospital’s
administrative database, all the patients who under-
went a lower extremity angiogram between January
1, 1989, and January 31, 1995, were identified.
From this set of admissions, all the patients who
underwent lower extremity angioplasty, arterial
bypass grafting, atherectomy, or amputation were
identified with ICD9 codes. For patients who had
more than one admission with one of these proce-
dures, only the first admission was used. The inten-
tion was to examine the patient’s outcome in the
years after the decision to perform a limb salvage
procedure rather than to examine the results from
any given procedure.
All the patients who were identified were sent a
letter asking for their consent to be surveyed and for
their chart to be reviewed. The letter described the
study and assured the participants that their answers
would not be shared with those who cared for
them—unless a registered nurse who reviewed the
responses felt a significant medical problem was pres -
ent and needed to be addressed. If there was no
response (either a return of the consent letter or a
note that the patient was deceased) after two mail-
ings, attempts were undertaken to locate the patient
by phone (telephoning the patient, relatives, or
neighbors) to assure that the address was correct and
that the patient was not deceased. The Minnesota
death certificates were searched for those individuals
who could not be located to ascertain whether they
were deceased.
Two types of data were collected for the study:
chart abstraction and telephone survey. All the
charts were reviewed by a registered nurse who was
trained in medical records abstraction. The nurse
underwent a training period in which the nurse and
one of the study authors (J. H.) reviewed a series of
charts. When there were no discrepancies between
the data of the two reviewers, the nurse was allowed
to review the charts independently.
The charts were reviewed to determine whether
the patient qualified for the study. A patient qualified
if the first arterial surgery or angioplasty of the ves-
sels distal to the aortic bifurcation was performed at
the University of Minnesota Hospital after January
1, 1989. Patients were excluded if they had under-
gone such a procedure on either side before 1989 or
if they had undergone such a procedure after 1989
but the first procedure was not at the University of
Minnesota. For the patients who had undergone
more than one qualifying procedure after January
1989, the first procedure was used for further chart
abstraction and analysis.
The charts of all the patients who qualified were
reviewed to assess the procedure undergone (bypass
grafting or angioplasty and which limb), the basic
demographic information, and whether the patient
was a current smoker. Further data on the patient’s
peripheral arterial disease included the presence of
preoperative rest pain, claudication, and leg or foot
ulcer. Preoperative comorbidities, including the
presence of atherosclerotic coronary vascular disease
and diabetes, and the comorbidities contained with-
in the Charlson comorbidity index14 were collected.
Finally, the walking status of the patient before the
operation was abstracted. (An attempt was made to
ascertain the walking status at baseline before any
acute event that precipitated hospitalization.)
All the living patients who qualified for the study
were interviewed on the telephone by a trained
interviewer. The data that were collected included
whether the patient had undergone an amputation
(defined as the foot or above) of that limb since the
qualifying procedure and the year of amputation.
Patients were interviewed as to whether at present
they were ambulatory and, if so, whether they
ambulated independently. For the patients who
required assistance for ambulation, the type of assis-
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tance (eg, cane, walker, other individual) was ascer-
tained. Whether the patient had claudication was
assessed with the Edinburgh Claudication question-
naire, which has been shown to be a reliable and
valid measure of the presence of claudication.15
Patient quality of life was assessed with the SF-1216
and the SF-36 physical function, role-physical, and
pain subscales.17 To decrease subject burden, the
entire SF-36 was not used.
Because amputation status could not be ascer-
tained through interview for the deceased patients,
the last available hospital and clinic charts were
reviewed to determine whether they had undergone
an amputation of the qualifying limb before death
and, if so, when. The date of death was determined
from those who were contacted in attempts to locate
the patient (eg, family members), the hospital or
clinic charts, or from the death certificates.
Analysis. The Charlson comorbidity index, the
grade of claudication from the Edinburgh Claudication
questionnaire, and the SF-12 and SF-36 scales 
were calculated as described in the literature.18,19
Differences in means and proportions were tested with
t test and c 2 test as appropriate for unadjusted analyses.
The differences in means and proportions after
adjustments for other factors were tested with mul-
tiple regression or logistic regression, respectively.
The significance test used was the P value of the
coefficient of the variable defining the groups. In all
regressions, all the variables that were believed to be
important were included in the model.
Patient survival and limb survival rates were
examined with Kaplan-Meier method plots. When
only the year of amputation was known, June 30 of
that year was used as the date of amputation. For
patients for whom a date of amputation or death was
missing, the last date that the patient was confirmed
to be alive (or nonamputated) was used. For many
patients, this was the date of the incident procedure.
This conservative approach biases the curves such
that the early portion of the survival curves appear
worse than they really are. Analysis was performed
with SPSS version 6.0 (SPSS, Inc, Chicago, Ill).
RESULTS
From the University of Minnesota Hospital’s
administrative database, 623 patients were identified
as having undergone lower extremity angiography
and lower extremity arterial bypass grafting, angio-
plasty (iliac or below), or amputation between
January 1, 1989, and January 31, 1995. Of these
patients, 495 (79%) gave consent for participation in
the study or were identified as dead, and all 495 charts
were reviewed. Of these patients, 166 were found on
chart review to not qualify for the study—nine under-
went primary amputation, six had procedures other
than a revascularization procedure, and 151 had their
first revascularization before January 1, 1989, or at an
institution other than the University of Minnesota. Of
the 329 remaining subjects, 166 were living and 163
were deceased. All the living patients were surveyed.
Of the qualifying patients, 62.6% had undergone
arterial bypass grafting as the qualifying procedure,
36.8% had undergone angioplasty, and 0.6% were
noted to have undergone atherectomy. The time
between the procedure and follow-up examination
averaged 4.9 years (range, 1.5 to 7.6 years).
Characteristics of the study population are shown in
Table I. The mean age of the population at the time
of the qualifying procedure was 63 years. Diabetes
was present in 64% of the population, and nearly half
of the patients had known coronary vascular disease.
Rest pain was noted in 27% of the population, and
63% had a lower extremity skin ulcer. The mean
Charlson comorbidity index was 4.2 (range, 1 to
13). Those patients who were dead at the time of
the follow-up examination were, on average, 10
years older at the time of the qualifying procedure
than those patients who were still living (deceased,
68 years old; living, 58 years old; P < .001). In addi-
tion, a greater percentage of the patients who were
dead at the follow-up examination had coronary vas-
cular disease or a lower extremity skin ulcer. A small-
er percentage of these patients had claudication or
could walk without assistance.
Between the incident procedure and the follow-
up examination, 16.9% of the patients who were still
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Table I. Percent of study population with baseline
characteristics overall and by mortality status at fol-
low-up examination
Total Living Deceased
Preoperative characteristics (n = 329) (n = 166) (n = 163)
Male gender 56 59 53
Claudication 48 57 40*
Rest pain 27 25 29
Lower extremity skin ulcer 63 54 71*
Walking with assistance 16 10 21†
Walking without assistance 80 88 71‡
Smoker 23 24 21
Known coronary vascular disease 49 43 55§





alive and 16.6% of the patients who had died had
undergone a major amputation of the qualifying
limb. Overall, 16.7% of the total population had
undergone an amputation of the qualifying limb.
The survival of the qualifying limb (ie, no ampu-
tation) and the survival of the patient over time were
examined with survival analysis (Fig 1). One compli-
cating factor is that the patient follow-up time varied
from 1 to 7 years, depending on the year of the qual-
ifying procedure. To clarify this in the results, the
number of patients who remained vulnerable for the
event of interest at each year after the qualifying pro-
cedure is shown along the survival curve.
The upper line in Fig 1 shows the survival of the
limb from the time of the qualifying procedure with
censoring of the patients who died. At 7 years, 73%
of the patients who were still alive still had the limb
that was salvaged. For those patients who required
amputation, the mean time between the qualifying
intervention and amputation was 1.41 years (range,
0 to 6.5 years). The overall mortality rate of the
patients over time is shown by the lower line in Fig
1. By 7 years of follow-up, 63% of the population
had died.
The ambulation status of the patients who were
alive at follow-up examination is shown in Table II.
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Fig. 1. Percentage with qualifying limb and percentage alive by time from qualifying proce-
dure.
Table II. Ambulation status (%) at follow-up examination for the total population, those with intact limb,
and those with amputation of the qualifying limb at follow-up examination
Total Intact limb Amputated limb
(n = 166) (n = 138) (n = 28)
Walking independently 65 70 36*
Walking with assistance 28 25 43
Little or no limitation in walking more than a mile 27 32 4†
Little or no limitation in walking several blocks 43 50 11*
Little or no limitation in walking one block 71 76 43*
*P < .001.
†P = .002.
Overall, at follow-up examination (1 to 7 years after
the initial procedure), 65% of the patients were walk-
ing independently. Further, 43% of the patients
reported little or no limitation in walking several
blocks and 71% of patients reported the ability to
walk one block with little or no limitation. A small-
er percentage of patients who had undergone an
amputation by follow-up examination could walk
independently (36%; P < .001), and fewer reported
that they could walk either shorter (43%; P < .001)
or longer distances (11%; P < .001) with little or no
limitation.
The results of a multiple logistic regression
analysis that examined the factors that predict inde-
pendent ambulation at follow-up examination is pre-
sented in Table III. Patients with diabetes were 20%
as likely to be walking at follow-up examination as
patients without diabetes (odds ratio, 0.19; P =
.0031). Older patients were also statistically less like-
ly to be walking independently at follow-up exami-
nation. None of the other factors, including the
number of years since the procedure, were indepen-
dent predictors of walking status.
Global physical function was assessed with the
SF-36 physical function subscale. The overall mean
physical function score for patients at follow-up
examination was 42, with a standard deviation (SD)
of 30. (For comparison, studies of patients with
claudication have found scores between 41 and
53,20,21 and, in the Medical Outcomes study,
patients with congestive heart failure had a mean
score of 64 and patients who had had a myocardial
infarction within 12 months had a score of 60).22
The coefficients from a multiple regression analysis
that examined the predictors of physical function at
follow-up examination are shown in Table III (a
negative value means that a factor decreases the
quality of life). Again, we found that only patient age
and diabetes were significant predictors. On average,
after controlling for other variables, preoperative
diabetes decreased an individual’s SF-36 physical
function score at follow-up examination by 21.54 (P
= .0006) and each year in increasing age decreased
the score by 0.46 (P = .0032). Other factors, includ-
ing whether the initial procedure was a bypass graft-
ing procedure and the number of years since the
procedure, were not significant predictors.
Finally, overall physical health and overall mental
health was assessed with the SF-12. The mean SF-12
physical health and mental health scores were 36
(SD, 10) and 53 (SD, 10), respectively. (For com-
parison from the Medical Outcomes study, patients
with congestive heart failure had scores of 40 and 51
and those with a myocardial infarction within a year
had scores of 42 and 51.)18 In a multiple regression
analysis of overall physical health (Table IV), greater
patient age and the presence of diabetes were the
only factors that were significantly associated with
overall physical health (both negatively). The only
factor that was significantly associated with overall
mental health in this study was whether the patient
had undergone bypass grafting. These patients had
an average of 4.5 points more on the mental health
score (range, 0 to 100).
DISCUSSION
Peripheral vascular disease can cause significant
morbidity, particularly when the disease progresses
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Table III. Odds ratio of walking independently at follow-up examination and regression coefficients for
SF-36 physical function with 95% confidence interval for patient preoperative factors, years since procedure,
and primary procedure
Factor Independent walking (odds ratios) SF-36 physical function (regression coefficients)
Age 0.97 (0.94, 1.00) -0.46 (-0.76, -0.16)
Male gender 1.62 (0.69, 3.80) 8.49 (-0.74, 17.72)
Diabetes 0.19 (0.06, 0.57) -21.54 (-33.63, -9.45)
Rest pain 0.55 (0.21, 1.46) -2.97 (-13.49, 7.54)
Smoker 1.04 (0.36, 3.00) 3.91 (-7.03, 14.85)
Claudication 0.92 (0.33, 2.62) -1.39 (-12.46, 9.69)
Lower extremity skin ulcer 0.58 (0.20, 1.64) -1.22 (-12.52, 10.08)
Walking with assistance 1.07 (0.05, 24.22) 1.48 (-32.60, 35.55)
Walking without assistance 8.25 (0.51, 134.55) 16.79 (-14.51, 48.08)
Charlson comorbidity index 0.88 (0.70, 1.12) -1.61 (-4.28, 1.05)
Coronary vascular disease 1.16 (0.49, 2.73) 1.91 (-7.74, 11.56)
Years since procedure 0.96 (0.76, 1.21) 0.78 (-1.78, 3.33)
Bypass grafting was qualifying procedure 1.58 (0.63, 4.01) 1.96 (-8.07, 11.99)
Odds ratios for nondichotomous variables (age, Charlson score, and years since procedure) are for a one-unit change in the variable.
P < =.05, in bold.
to the point where the limb is threatened. The liter-
ature suggests that it is possible to save many of
these threatened limbs. What is less clear is how the
patients then do in the long term.
Our data expand on what has been noted in the
literature previously—intervention is effective at
limb salvage, but this population has a high mortal-
ity rate. In our study, by 7 years, only 27% of the
patients had undergone an amputation of the sal-
vaged limb but 63% of the patients had died.
Therefore, only 27% of all the patients were still alive
with the limb. These rates are similar to those
reported by others for populations with similar
comorbidities,2,3,13,23,24 and the mortality rate is
similar to those rates in nonoperated populations
with similar degrees of peripheral vascular disease.24
For those patients who do survive, the outlook is
not grim. In our study, 65% of patients at follow-up
examination were able to walk independently and
43% of the patients were able to walk several blocks
with little or no limitation. The data also suggest
that patients derived benefit from the revasculariza-
tion because the patients who subsequently under-
went an amputation had a far worse status (only 36%
could walk independently and only 11% could walk
several blocks), although it must be remembered
that part of this worse ambulation status may be
caused by overall worse disease. Also, the ambula-
tion status is preserved over time; we did not find
that the length of time since the procedure was a sig-
nificant predictor of independent ambulation in the
multiple regression equation.
In our multiple regression analyses of the effect
of baseline characteristics on mental health, the only
baseline characteristic that was predictive was
whether bypass grafting was the initial procedure. It
is not clear from our data what the mechanism for
this may be. It is possible that patients who are
believed to be best treated with bypass grafting are
in some way different in their mental health at base-
line or that something about the subsequent course,
such as the number of subsequent procedures neces-
sary, affects mental health.
In our multiple regression analyses of the effect
of baseline characteristics on functional health status,
overall physical health status, and independent
ambulation, only age and diabetes were significant
predictors. It is not surprising that the presence of
diabetes with its significant comorbid burden would
adversely effect functional outcome nor that increas-
ing age would as well. It may be somewhat surpris-
ing that the other factors that one might expect to
be significant (such as baseline ambulation status or
claudication) are not. It is possible as discussed that
these baseline factors have an effect but that any
effect is overwhelmed by what happens to the
patient subsequently.
In this study, we specifically wanted to examine
what the outcomes of patients were in the years sub-
sequent to the decision to revascularize their limbs
regardless of what other procedures they may or may
not have required. This allowed us to understand the
outcomes after the decision to take the path of revas-
cularization. We did not gain insight into the effect
on outcome of other events (eg, additional vascular
procedures, amputation of the contralateral limb, or
comorbid events, such as myocardial infarction or
cerebrovascular accident) that may have occurred
along that path. Because these events may affect a
patient’s outcome, it may in the future be interesting
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Table IV. Regression coefficients for SF-12 physical health and mental health scores with 95% confidence
interval for patient preoperative factors, years since procedure, and primary procedure
Factor Physical health Mental health
Age –0.15 (–0.26, –0.037) 0.03 (–0.09, 0.15)
Male gender .37 (–3.04, 3.79) –0.38 (–4.10, 3.33)
Diabetes –5.07 (–9.54, –0.61) 0.31 (–4.55, 5.18)
Rest pain –2.00 (–5.89, 1.88) 0.47 (–3.76, 4.71)
Smoker 1.94 (–2.10, 5.99) –0.84 (–5.25, 3.56)
Claudication 0.42 (–3.67, 4.51) 2.71 (–1.75, 7.17)
Lower extremity skin ulcer 0.85 (–3.33, 5.03) 1.96 (–2.59, 6.51)
Walking with assistance –4.14 (–16.74, 8.45) –6.69 (–20.41, 7.03)
Walking without assistance –3.69 (–15.26, 7.88) –1.05 (–13.65, 11.55)
Charlson comorbidity index –.088 (–1.86, 0.11) 0.07 (–1.00, 1.14)
Coronary vascular disease 0.78 (–2.79, 4.35) 0.81 (–3.07, 4.70)
Years since procedure 0.39 (–0.56, 1.33) 0.31 (–0.72, 1.34)
Bypass grafting was qualifying procedure 2.12 (–1.59, 5.82) 4.48 (0.45, 8.52)
P < .05, in bold.
to model events and decisions along the revascular-
ization path to gain better insight into those factors.
In generalizing the overall outcomes from this
study to other populations, it is important to keep
the demographic characteristics and comorbidities
of the particular population in mind. For example, in
this study, 64% of the subjects have diabetes, which,
as we demonstrated, is an important predictor of
outcome in peripheral vascular disease. This percent-
age is higher than that in most series (range, approx-
imately 15% to 50%)4,11,12 probably because the
University of Minnesota serves as a significant refer-
ral site for diabetes itself and a number of related dis-
eases. Thus, the overall results in an unselected pop-
ulation might be proportionately better.
Although outcome information in this study was
acquired through the use of a telephone survey
rather than direct observation, we believe that it most
likely accurately reflects the status of the subjects.
The SF-36 has been found to be a valid measure of
health status25 and to be comparable when adminis-
tered by telephone or face to face.26 One concern
might be that the patients may provide biased
answers because the same surgical group that per-
formed their surgery is doing the study (for example,
the patients might rate their health as better than it
really is). That subjects in this study were told that
their answers would not be shared with those caring
for them should have decreased any possible effect.
One limitation of this study was that 21% of the
potential study population was excluded because of
lack of consent, usually because the patient could
not be located. It is unclear how this sample loss
biased the findings. We may have missed deceased
individuals who would not return a consent card;
however, we supplemented the consent process with
a search of death certificates that should reduce this
bias. Further, it is unclear whether the living patients
who were missed are likely to have any better or
worse status at present than those who were found.
Finally, it is possible that we may have underestimat-
ed the percentage of deceased patients who under-
went amputation because this procedure could have
occurred elsewhere and not been captured in our
chart review. But the completeness of follow-up
found in the charts leads us to believe this is likely to
be a small percentage of the sample.
Patients who undergo limb revascularization are
likely to keep the salvaged limb for many years and be
able to ambulate on it. The overall time the average
person enjoys this benefit is unfortunately somewhat
limited by the underlying disease process; most of the
patients are dead 5 years after the intervention. Further
improvements in the outcomes of these patients will
necessitate not better interventions but better means
of preventing and managing the effect of the underly-
ing disease on the vascular system as a whole. 
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